RI S2863

Requires health insurers to reimburse for up to 365 days of prescription hormone therapy dispensed at one time, beginning the first plan year after January 1, 2027

Defines prescription hormone therapy as FDA-approved drugs that suppress, increase, or replace hormones, including necessary administration supplies, but explicitly excludes GLP-1 and GLP-1 receptor agonists

Allows smaller supplies if requested by the enrollee, directed by the prescriber, or if the medication is a controlled substance (in which case the maximum legal refill applies)

Applies to individual and group health insurance policies, nonprofit hospital and medical service corporations, HMOs, and Medicaid beneficiaries

Requires the Executive Office of Health and Human Services to submit a Medicaid state plan amendment within 90 days of the act's effective date to implement the requirement for Medicaid recipients